November 12, 2010 — The US Food and Drug Administration (FDA) has approved tesamorelin acetate injection (Egrifta; Theratechnologies, Inc, and marketed by EMD Serono) as the first and only treatment ...

According to Theratechnologies, Egrifta WR is set to replace Egrifta SV. The Food and Drug Administration (FDA) has approved Egrifta WR ™, a new concentrated formulation (F8) of tesamorelin, for the ...

HIV patients with end-stage renal disease may need increased nutritional intake. Few studies have looked at this population, but these patients may have very high energy needs. Highly active ...

Acquired Lipodystrophy is a condition where the body abnormally stores or loses fat, typically beneath the skin. Unlike congenital forms, acquired types develop later in life. Acquired Lipodystrophy ...